Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report

INTRODUCTION: There is currently no optimal treatment modality for refractory or relapsed Extranodal NK/T-cell lymphoma, nasal type (ENKTL). In recent years, programmed cell death protein 1 (PD-1)/programmed cell – ligand 1 pathway blockade and histone deacetylase inhibitors have emerged as promisin...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jingyan, Xu, Xihui, Chen, Jieyu, Wang, Jing, Jiang, Chong, Lv, Chenglan, Chen, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969288/
https://www.ncbi.nlm.nih.gov/pubmed/33725836
http://dx.doi.org/10.1097/MD.0000000000024824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969288/
https://www.ncbi.nlm.nih.gov/pubmed/33725836
http://dx.doi.org/10.1097/MD.0000000000024824

Ejemplares similares